Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

7.65USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$7.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,133
52-wk High
$11.30
52-wk Low
$5.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 9.06 -0.538
Jun '18 4.61 -0.683
Mar '18 3.97 -0.687
FY 2017 Dec '17 3.06 -0.714
Sep '17 23.01 -0.171
Jun '17 3.01 -0.694
Mar '17 3.02 -0.631
FY 2016 Dec '16 3.04 -0.626
Sep '16 13.02 -0.464
Jun '16 3.00 -0.705
Mar '16 0.00 -1.308
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 7 11.57 43.00 0.00 3.00
Quarter Ending Mar-19 4 18.73 43.40 3.00 3.00
Year Ending Dec-18 7 28.54 60.64 17.64 17.24
Year Ending Dec-19 7 47.19 67.33 12.00 38.00
Earnings (per share)
Quarter Ending Dec-18 7 -0.53 0.24 -0.78 -0.82
Quarter Ending Mar-19 4 -0.34 0.20 -0.72 -0.73
Year Ending Dec-18 7 -2.43 -1.63 -2.69 -2.84
Year Ending Dec-19 7 -1.95 -1.44 -2.31 -2.36
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) 21.87 116.41 5.77
Price to Book (MRQ) 5.48 15.60 5.12
Price to Tangible Book (MRQ) 5.49 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 78.85 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.30 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago 286.35 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -0.69 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -16.86 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 6.86 5.42 3.11
LT Debt to Equity (MRQ) 11.21 33.58 11.47
Total Debt to Equity (MRQ) 11.21 35.41 15.63
Interest Coverage (TTM) -- -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -419.56 -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -448.70 -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -441.38 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -441.38 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 173,858 25,687,363 898,926,015
Net Income/Employee (TTM) -767,370 2,194,067 106,550,787
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.08 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.30 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -41.51 0.28 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -76.34 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Seres Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.99 -19.85 17 57
13 Week 7.00 1.79 99 62
26 Week 9.86 1.51 99 81
52 Week 4.47 -11.45 99 47
YTD 20.40 5.74 99 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.70%
# of Holders: 115
Total Shares Held: 32,152,827
3 Mo. Net Change: 214,576
# New Positions: 5
# Closed Positions: 12
# Increased Positions: 45
# Reduced Positions: 34
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.